Recent Updates
Recently added Catalysts
MYO Positive Sentiment

Myomo to Report First Quarter 2025 Financial Results on May 7

Wednesday, April 30, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Myomo, Inc. has announced that it will report its financial results for the first quarter of 2025 on May 7, 2025. This report will cover the period ending March 31, 2025. The company specializes in wearable medical robotics aimed at assisting those with neurological disorders and upper-limb paralysis.
Price reaction · baseline $4.655 (2025-04-30T16:05:00.000Z) · hit during market hours · 1 other MYO headline(s) in the window, move may be shared
day 0 close · peak
+1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myomo is actively engaging with its financial reporting.
  • The company is focused on improving the lives of individuals with neurological disorders.
  • Reporting financial results indicates transparency and accountability.

Full Press Release Details

BURLINGTON, Mass. (April 30, 2025) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2025 on May 7, 2025. Read more .

Frequently Asked Questions

When will Myomo report its Q1 2025 financial results?

Myomo will report its Q1 2025 financial results on May 7, 2025.

What period will Myomo's financial results cover?

The financial results will cover the period ending March 31, 2025.

What does Myomo specialize in?

Myomo specializes in wearable medical robotics for neurological disorders.

ShareAdd on Google
Tags: MYO Viatris Investor Conferences Healthcare Myomo financial results wearable robotics neurological disorders upper-limb paralysis
Last updated: Apr 30, 2025

Biotech snapshot

Cash runway
$13M liquidity · $1M/mo burn
~20 mo
Low dilution risk